000124380 001__ 124380
000124380 005__ 20240228145510.0
000124380 0247_ $$2doi$$a10.1038/gim.2016.147
000124380 0247_ $$2pmid$$apmid:27711073
000124380 0247_ $$2pmc$$apmc:PMC5382131
000124380 0247_ $$2ISSN$$a1098-3600
000124380 0247_ $$2ISSN$$a1530-0366
000124380 0247_ $$2altmetric$$aaltmetric:12511619
000124380 037__ $$aDKFZ-2017-01259
000124380 041__ $$aeng
000124380 082__ $$a570
000124380 1001_ $$00000-0002-5895-1808$$aMuranen, Taru A$$b0
000124380 245__ $$aGenetic modifiers of CHEK2*1100delC-associated breast cancer risk.
000124380 260__ $$aBaltimore, Md.$$bLippincott, Williams & Wilkins$$c2017
000124380 3367_ $$2DRIVER$$aarticle
000124380 3367_ $$2DataCite$$aOutput Types/Journal article
000124380 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1660822376_27718
000124380 3367_ $$2BibTeX$$aARTICLE
000124380 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000124380 3367_ $$00$$2EndNote$$aJournal Article
000124380 520__ $$aCHEK2*1100delC is a founder variant in European populations that confers a two- to threefold increased risk of breast cancer (BC). Epidemiologic and family studies have suggested that the risk associated with CHEK2*1100delC is modified by other genetic factors in a multiplicative fashion. We have investigated this empirically using data from the Breast Cancer Association Consortium (BCAC).Using genotype data from 39,139 (624 1100delC carriers) BC patients and 40,063 (224) healthy controls from 32 BCAC studies, we analyzed the combined risk effects of CHEK2*1100delC and 77 common variants in terms of a polygenic risk score (PRS) and pairwise interaction.The PRS conferred odds ratios (OR) of 1.59 (95% CI: 1.21-2.09) per standard deviation for BC for CHEK2*1100delC carriers and 1.58 (1.55-1.62) for noncarriers. No evidence of deviation from the multiplicative model was found. The OR for the highest quintile of the PRS was 2.03 (0.86-4.78) for CHEK2*1100delC carriers, placing them in the high risk category according to UK NICE guidelines. The OR for the lowest quintile was 0.52 (0.16-1.74), indicating a lifetime risk close to the population average.Our results confirm the multiplicative nature of risk effects conferred by CHEK2*1100delC and the common susceptibility variants. Furthermore, the PRS could identify carriers at a high lifetime risk for clinical actions.Genet Med advance online publication 06 October 2016.
000124380 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000124380 588__ $$aDataset connected to CrossRef, PubMed,
000124380 7001_ $$aGreco, Dario$$b1
000124380 7001_ $$00000-0003-3041-1938$$aBlomqvist, Carl$$b2
000124380 7001_ $$aAittomäki, Kristiina$$b3
000124380 7001_ $$00000-0003-4185-8882$$aKhan, Sofia$$b4
000124380 7001_ $$00000-0002-5883-9517$$aHogervorst, Frans$$b5
000124380 7001_ $$aVerhoef, Senno$$b6
000124380 7001_ $$00000-0001-8494-732X$$aPharoah, Paul D P$$b7
000124380 7001_ $$00000-0001-6651-7166$$aDunning, Alison M$$b8
000124380 7001_ $$aShah, Mitul$$b9
000124380 7001_ $$aLuben, Robert$$b10
000124380 7001_ $$aBojesen, Stig E$$b11
000124380 7001_ $$aNordestgaard, Børge G$$b12
000124380 7001_ $$aSchoemaker, Minouk$$b13
000124380 7001_ $$00000-0001-5550-4159$$aSwerdlow, Anthony$$b14
000124380 7001_ $$aGarcía-Closas, Montserrat$$b15
000124380 7001_ $$aFigueroa, Jonine$$b16
000124380 7001_ $$aDörk, Thilo$$b17
000124380 7001_ $$aBogdanova, Natalia V$$b18
000124380 7001_ $$aHall, Per$$b19
000124380 7001_ $$00000-0001-8587-7511$$aLi, Jingmei$$b20
000124380 7001_ $$aKhusnutdinova, Elza$$b21
000124380 7001_ $$aBermisheva, Marina$$b22
000124380 7001_ $$aKristensen, Vessela$$b23
000124380 7001_ $$aBorresen-Dale, Anne-Lise$$b24
000124380 7001_ $$aInvestigators, Nbcs$$b25
000124380 7001_ $$00000-0002-1685-8912$$aPeto, Julian$$b26
000124380 7001_ $$aDos Santos Silva, Isabel$$b27
000124380 7001_ $$aCouch, Fergus J$$b28
000124380 7001_ $$00000-0003-4944-7789$$aOlson, Janet E$$b29
000124380 7001_ $$00000-0001-9829-3531$$aHillemans, Peter$$b30
000124380 7001_ $$00000-0002-2863-3040$$aPark-Simon, Tjoung-Won$$b31
000124380 7001_ $$0P:(DE-HGF)0$$aBrauch, Hiltrud$$b32
000124380 7001_ $$00000-0001-6705-7624$$aHamann, Ute$$b33
000124380 7001_ $$0P:(DE-He78)15b7fd2bc02d5ef47a2fe2dd0140d2bf$$aBurwinkel, Barbara$$b34
000124380 7001_ $$aMarme, Frederik$$b35
000124380 7001_ $$aMeindl, Alfons$$b36
000124380 7001_ $$aSchmutzler, Rita K$$b37
000124380 7001_ $$00000-0002-5138-1099$$aCox, Angela$$b38
000124380 7001_ $$aCross, Simon S$$b39
000124380 7001_ $$aSawyer, Elinor J$$b40
000124380 7001_ $$aTomlinson, Ian$$b41
000124380 7001_ $$aLambrechts, Diether$$b42
000124380 7001_ $$00000-0001-8880-9311$$aMoisse, Matthieu$$b43
000124380 7001_ $$00000-0001-7675-7569$$aLindblom, Annika$$b44
000124380 7001_ $$aMargolin, Sara$$b45
000124380 7001_ $$00000-0003-1166-1966$$aHollestelle, Antoinette$$b46
000124380 7001_ $$aMartens, John W M$$b47
000124380 7001_ $$aFasching, Peter A$$b48
000124380 7001_ $$aBeckmann, Matthias W$$b49
000124380 7001_ $$aAndrulis, Irene L$$b50
000124380 7001_ $$aKnight, Julia A$$b51
000124380 7001_ $$aInvestigators, kConFab/Aocs$$b52
000124380 7001_ $$aAnton-Culver, Hoda$$b53
000124380 7001_ $$00000-0003-4529-3727$$aZiogas, Argyrios$$b54
000124380 7001_ $$aGiles, Graham G$$b55
000124380 7001_ $$aMilne, Roger L$$b56
000124380 7001_ $$0P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aBrenner, Hermann$$b57
000124380 7001_ $$0P:(DE-He78)d023fdf423d87ee6c710e34dd7581fa0$$aArndt, Volker$$b58
000124380 7001_ $$aMannermaa, Arto$$b59
000124380 7001_ $$aKosma, Veli-Matti$$b60
000124380 7001_ $$0P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253$$aChang, Jenny$$b61
000124380 7001_ $$00000-0001-7520-2035$$aRudolph, Anja$$b62
000124380 7001_ $$00000-0002-8023-2009$$aDevilee, Peter$$b63
000124380 7001_ $$aSeynaeve, Caroline$$b64
000124380 7001_ $$00000-0002-8567-173X$$aHopper, John L$$b65
000124380 7001_ $$00000-0002-6313-9005$$aSouthey, Melissa C$$b66
000124380 7001_ $$aJohn, Esther M$$b67
000124380 7001_ $$aWhittemore, Alice S$$b68
000124380 7001_ $$aBolla, Manjeet K$$b69
000124380 7001_ $$00000-0002-9139-0627$$aWang, Qin$$b70
000124380 7001_ $$00000-0001-7065-1237$$aMichailidou, Kyriaki$$b71
000124380 7001_ $$00000-0003-4591-1214$$aDennis, Joe$$b72
000124380 7001_ $$00000-0003-2444-3247$$aEaston, Douglas F$$b73
000124380 7001_ $$aSchmidt, Marjanka K$$b74
000124380 7001_ $$aNevanlinna, Heli$$b75
000124380 773__ $$0PERI:(DE-600)2063504-7$$a10.1038/gim.2016.147$$gVol. 19, no. 5, p. 599 - 603$$n5$$p599 - 603$$tGenetics in medicine$$v19$$x1530-0366$$y2017
000124380 909CO $$ooai:inrepo02.dkfz.de:124380$$pVDB
000124380 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b32$$kDKFZ
000124380 9101_ $$0I:(DE-588b)2036810-0$$60000-0001-6705-7624$$aDeutsches Krebsforschungszentrum$$b33$$kDKFZ
000124380 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)15b7fd2bc02d5ef47a2fe2dd0140d2bf$$aDeutsches Krebsforschungszentrum$$b34$$kDKFZ
000124380 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aDeutsches Krebsforschungszentrum$$b57$$kDKFZ
000124380 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)d023fdf423d87ee6c710e34dd7581fa0$$aDeutsches Krebsforschungszentrum$$b58$$kDKFZ
000124380 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253$$aDeutsches Krebsforschungszentrum$$b61$$kDKFZ
000124380 9101_ $$0I:(DE-588b)2036810-0$$60000-0001-7520-2035$$aDeutsches Krebsforschungszentrum$$b62$$kDKFZ
000124380 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000124380 9141_ $$y2017
000124380 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000124380 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bGENET MED : 2015
000124380 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000124380 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000124380 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000124380 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000124380 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000124380 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000124380 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000124380 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000124380 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bGENET MED : 2015
000124380 9201_ $$0I:(DE-He78)B072-20160331$$kB072$$lMolekulargenetik des Mammakarzinoms$$x0
000124380 9201_ $$0I:(DE-He78)C080-20160331$$kC080$$lMolekulare Epidemiologie$$x1
000124380 9201_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x2
000124380 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x3
000124380 9201_ $$0I:(DE-He78)G110-20160331$$kG110$$lPräventive Onkologie$$x4
000124380 9201_ $$0I:(DE-He78)C071-20160331$$kC071$$lC071 Cancer Survivorship$$x5
000124380 9201_ $$0I:(DE-He78)L801-20160331$$kL801$$lDKTK Tübingen$$x6
000124380 9201_ $$0I:(DE-He78)L101-20160331$$kL101$$lDKTK Heidelberg$$x7
000124380 980__ $$ajournal
000124380 980__ $$aVDB
000124380 980__ $$aI:(DE-He78)B072-20160331
000124380 980__ $$aI:(DE-He78)C080-20160331
000124380 980__ $$aI:(DE-He78)C020-20160331
000124380 980__ $$aI:(DE-He78)C070-20160331
000124380 980__ $$aI:(DE-He78)G110-20160331
000124380 980__ $$aI:(DE-He78)C071-20160331
000124380 980__ $$aI:(DE-He78)L801-20160331
000124380 980__ $$aI:(DE-He78)L101-20160331
000124380 980__ $$aUNRESTRICTED